Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways

Cancer Letters

Volumn 328, Issue 2, 2013, Pages 353-361

  Noguchi, Shunsuke ^a   Yasui, Yuki ^a   Iwasaki, Junya ^a   Kumazaki, Minami ^a   Yamada, Nami ^a   Naito, Seiji ^b   Akao, Yukihiro ^a  

^a GIFU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Bladder cancer; MAPK; MicroRNA 143; MicroRNA 145; PI3K Akt

Indexed keywords

INTEGRIN LINKED KINASE; LUCIFERASE; MICRORNA 143; MICRORNA 145; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84870359532     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.017     Document Type: Article

References (38)

1. Sun B.S., Dong Q.Z., Ye Q.H., Sun H.J., Jia H.L., Zhu X.Q., Liu D.Y., Chen J., Xue Q., Zhou H.J., Ren N., Qin L.X. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 2008, 48:1834-1842.
2. Cannell I.G., Kong Y.W., Bushell M. How do microRNAs regulate gene expression?. Biochem. Soc. Trans. 2008, 36:1224-1231.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Chiang H.R., Schoenfeld L.W., Ruby J.G., Auyeung V.C., Spies N., Baek D., Johnston W.K., Russ C., Luo S., Babiarz J.E., Blelloch R., Schroth G.P., Nusbaum C., Bartel D.P. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 2010, 24:992-1009.
5. Harfe B.D. MicroRNAs in vertebrate development. Curr. Opin. Genet. Dev. 2005, 15:410-415.
6. Lynam-Lennon N., Maher S.G., Reynolds J.V. The roles of microRNA in cancer and apoptosis. Biol. Rev. Camb. Philos. Soc. 2009, 84:55-71.
7. Zhang J., Jima D.D., Jacobs C., Fischer R., Gottwein E., Huang G., Lugar P.L., Lagoo A.S., Rizzieri D.A., Friedman D.R., Weinberg J.B., Lipsky P.E., Dave S.S. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009, 113:4586-4594.
8. Kaddar T., Rouault J.P., Chien W.W., Chebel A., Gadoux M., Salles G., Ffrench M., Magaud J.P. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol. Cell 2009, 101:511-524.
9. Qiang R., Wang F., Shi L.Y., Liu M., Chen S., Wan H.Y., Li Y.X., Li X., Gao S.Y., Sun B.C., Tang H. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 2011, 43:632-641.
10. Catto J.W., Alcaraz A., Bjartell A.S., De Vere White R., Evans C.P., Fussel S., Hamdy F.C., Kallioniemi O., Mengual L., Schlomm T., Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 2011, 59:671-681.
11. P. Cao, L. Zhou, J. Zhang, F. Zheng, H. Wang, D. Ma, J. Tian, Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head Neck, in press.
12. Uziel T., Karginov F.V., Xie S., Parker J.S., Wang Y.D., Gajjar A., He L., Ellison D., Gilbertson R.J., Hannon G., Roussel M.F. The miR-17-92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc. Natl. Acad. Sci. USA 2009, 106:2812-2817.
13. Akao Y., Nakagawa Y., Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007, 26:311-320.
14. Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep. 2006, 16:845-850.
15. Lin T., Dong W., Huang J., Pan Q., Fan X., Zhang C., Huang L. MicroRNA-143 as a tumor suppressor for bladder cancer. J. Urol. 2009, 181:1372-1380.
16. Akao Y., Nakagawa Y., Kitade Y., Kinoshita T., Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007, 98:1914-1920.
17. Akao Y., Nakagawa Y., Iio A., Naoe T. Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leukemia Res. 2009, 33:1530-1538.
18. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene. Ther. 2010, 17:398-408.
19. Noguchi S., Mori T., Hoshino Y., Maruo K., Yamada N., Kitade Y., Naoe T., Akao Y. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 2011, 307:211-220.
20. Villadsen S.B., Bramsen J.B., Ostenfeld M.S., Wiklund E.D., Fristrup N., Gao S., Hansen T.B., Jensen T.I., Borre M., Orntoft T.F., Dyrskjot L., Kjems J. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br. J. Cancer 2012, 106:366-374.
21. Cho W.C. MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta 1805, 2010:209-217.
22. Cho W.C. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 2010, 42:1273-1281.
23. Cho W.C. Targeting the signaling pathways in cancer therapy. Expert. Opin. Ther. Targets 2012, 16:1-3.
24. Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010, 70:378-387.
25. Chiyomaru T., Enokida H., Tatarano S., Kawahara K., Uchida Y., Nishiyama K., Fujimura L., Kikkawa N., Seki N., Nakagawa M. MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 2010, 102:883-891.
26. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y.Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 2009, 106:3207-3212.
27. Ibrahim A.F., Weirauch U., Thomas M., Grunweller A., Hartmann R.K., Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res. 2011, 71:5214-5224.
28. Cho W.C., Chow A.S., Au J.S. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011, 8:125-131.
29. McDonald P.C., Fielding A.B., Dedhar S. Integrin-linked kinase-essential roles in physiology and cancer biology. J. Cell Sci. 2008, 121:3121-3132.
30. Hannigan G., Troussard A.A., Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat. Rev. Cancer 2005, 5:51-63.
31. Gao J., Zhu J., Li H.Y., Pan X.Y., Jiang R., Chen J.X. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Int. J. Biochem. Cell Biol. 2011, 43:1294-1304.
32. Naito S., Kotoh S., Koga H., Hasegawa S., Yamasaki T., Noma H., Kumazawa J. Establishment and characterization of two human bladder cancer cell lines. Hum. Cell 1996, 9:49-56.
33. Iio A., Nakagawa Y., Hirata I., Naoe T., Akao Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol. Cancer 2010, 9:136.
34. Nithianandarajah-Jones G.N., Wilm B., Goldring C.E., Muller J., Cross M.J. ERK5: structure, regulation and function. Cell Signal. 2012, 24:2187-2196.
35. Dyrskjot L., Ostenfeld M.S., Bramsen J.B., Silahtaroglu A.N., Lamy P., Ramanathan R., Fristrup N., Jensen J.L., Andersen C.L., Zieger K., Kauppinen S., Ulhoi B.P., Kjems J., Borre M., Orntoft T.F. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009, 69:4851-4860.
36. Sudbery I., Enright A.J., Fraser A.G., Dunham I. Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis. BMC Genomics 2010, 11:175.
37. Noguchi S., Mori T., Hoshino Y., Yamada N., Nakagawa T., Sasaki N., Akao Y., Maruo K. Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J. Vet. Med. Sci. 2012, 74:1-8.
38. Chen Z., Zeng H., Guo Y., Liu P., Pan H., Deng A., Hu J. MiRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J. Exp. Clin. Cancer Res. 2010, 29:151.